Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors

OncoImmunology

Volumn 1, Issue 9, 2012, Pages 1612-1613

  Amaddeo, Giuliana ^a,b   Guichard, Cécile ^a,b   Imbeaud, Sandrine ^a,b   Zucman Rossi, Jessica ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Exome sequencing; Hepatocellular carcinoma; IRF2; Oncogene; Tumor suppressor gene

Indexed keywords

APC PROTEIN; BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; INTERFERON REGULATORY FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN MDM2; PROTEIN P53; RAS PROTEIN; TRANSCRIPTION FACTOR NRF2; WNT PROTEIN;

APC GENE; ARID1A GENE; AXIN1 GENE; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CTNNB1 GENE; GENE DELETION; GENE IDENTIFICATION; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENETIC GAIN; GENOTOXICITY; HEPATITIS B; HEPATITIS C; HUMAN; IRF2 GENE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NFE2L2 GENE; NONHUMAN; NOTE; ONCOGENE; PRIORITY JOURNAL; RPS6K3 GENE; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 84886903971     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21480     Document Type: Note

References (10)

1. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44:694-8; PMID:22561517; http://dx.doi.org/10.1038/ng.2256.
2. Nault JC, Zucman-Rossi J. Genetics of hepatobiliary carcinogenesis. Semin Liver Dis 2011; 31:173-87; PMID:21538283; http://dx.doi.org/10.1055/s-0031-1276646.
3. Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009; 457:200-4; PMID:19020503; http://dx.doi.org/10.1038/nature07475.
4. Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Tercé F, et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem 2007; 282:14437- 46; PMID:17379603; http://dx.doi.org/10.1074/jbc.M610725200.
5. Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 2011; 43:828-9; PMID:21822264; http://dx.doi.org/10.1038/ng.903.
6. Tamura T, Yanai H, Savitsky D, Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 2008; 26:535-84; PMID:18303999; http://dx.doi.org/10.1146/annurev.immunol.26.021607.090400.
7. Pettersson S, Kelleher M, Pion E, Wallace M, Ball KL. Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF- 2. Biochem J 2009; 418:575-85; PMID:19032150; http://dx.doi.org/10.1042/BJ20082087.
8. Boyault S, Rickman DS, de Reyniès A, Balabaud C, Rebouissou S, Jeannot E, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007; 45:42- 52; PMID:17187432; http://dx.doi.org/10.1002/hep.21467.
9. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 2012; 44:760-4; PMID:22634756; http://dx.doi.org/10.1038/ng.2291.
10. Hainaut P, Pfeifer GP. Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001; 22:367-74; PMID:11238174; http://dx.doi.org/10.1093/carcin/22.3.367.